OptimizeRx to Present at Investor Conferences in May

ROCHESTER, Mich., April 23, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform for the pharmaceutical industry, has been invited to present at three institutional investor conferences in May.

Event: Oppenheimer Emerging Growth ConferenceDate: May 14, 2019Location: InterContinental Barclay Hotel in NYCFormat: 1x1 meetingsRegistration: Please contact your Oppenheimer & Co. Inc. institutional sales representative

Event: B. Riley FBR Investor ConferenceDate: May 22-23, 2019Location: The Beverly Hilton Hotel in Beverly Hills, CaliforniaFormat: 1x1 meetings and presentationPresentation time: 1:00 p.m. Pacific timeWebcast: click hereRegistration: email [email protected] or click here

Event: Ladenburg Thalmann Technology Expo 2019 Date: May 30, 2019Location: 101 Park Avenue in NYCFormat: 1x1 meetings and presentationPresentation time: 4:00 p.m. Eastern timeRegistration: click here

These events are designed to give institutional analysts and investors the opportunity to meet with OptimizeRx management. They will be discussing a number of topics, including the company’s record results for the fourth quarter of 2018, the acquisition of CareSpeak Communications, and growth of the company’s digital health platform. The network has become the largest of its kind, now reaching more than half of the ambulatory patient market in the U.S.

The company recently reported its seventh sequential quarter of revenue growth, driving 2018 revenue up 75% to a record $21.2 million and the company’s first year of profitability. The company plans to maintain a gross margin target of at least 55% in 2019, as new digital health messaging pharma clients and programs ramp up.

To schedule a one-on-one meeting with OptimizeRx, you may submit your request via the links provided upon your registration for the conferences. For any questions about the company, please contact Ron Both of CMA at (949) 432-7557 or submit your request here.

About OptimizeRxOptimizeRx® (NASDAQ: OPRX), a digital health company, connects pharmaceutical companies to patients and providers, offering greater affordability, adherence and brand awareness at the point-of-care. As the nation’s largest point-of-prescribe promotional platform for the pharmaceutical industry, OptimizeRx provides a direct channel for pharma companies to communicate with healthcare providers right within their workflow and also directly to patients.

The cloud-based solution supports patient adherence to medications and better healthcare outcomes with real-time access to financial assistance, prior authorization, education and critical clinical information. OptimizeRx provides more than half of the ambulatory patient market with access to these benefits through leading EHR platforms like Allscripts, Amazing Charts and Quest, and directly via its mobile communications platform. 

For more information, follow the company on Twitter, LinkedIn or visit www.optimizerx.com.

Important Cautions Regarding Forward Looking Statements This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

OptimizeRx ContactDoug Baker, CFOTel (248) 651-6568 x807[email protected] 

Media Relations ContactNicole Brooks, Innsena CommunicationsTel (860) 800-2344[email protected]

Investor Relations ContactRon Both, CMATel (949) 432-7557[email protected]

Source: OptimizeRx Corporation

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Discovery Energy Metals plans private placement of up to $1.25M
• Leyden Horsemanship Opens Lessons, Boarding & Leases at Ocean View
• New Crypto Presale Just Launched: $BULLSKI Opens Stage One on Ethereum in the First Days of a 16-Stage Sale